{
"info": {
"nct_id": "NCT03658772",
"official_title": "An Open-label, Single-arm, Phase 1b Study to Evaluate the Safety and Efficacy of Grapiprant (ARY-007) in Combination With Pembolizumab in Patients With Advanced or Progressive Microsatellite Stable (MSS) Colorectal Cancer (CRC)",
"inclusion_criteria": "* Male and female adult patients 18 years of age or older on day of signing informed consent.\n* Patients must have a histologically confirmed advanced, metastatic, or progressive Microsatellite Stable (MSS) Colorectal Cancer (CRC) per institutional standards.\n* Patient has received at least two prior lines of therapy for advanced or metastatic CRC, at least one of which included fluorouracil.\n* Highly effective birth control.\n* Measurable disease.\n* Accessible tumor that can be safely accessed for multiple core biopsies and patient is willing to provide tissue from newly obtain biopsies before and during treatment.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.\n* Adequate organ function.\n* Able to swallow and absorb oral tablets.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor\n* Current use of NSAIDs, COX-2 inhibitors and aspirin products within 3 days (preferably 7 days) before treatment initiation or at anytime during the study unless used for management of AE.\n* History of severe hypersensitivity reactions to chimeric or humanized antibodies\n* Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.\n* Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study drug.\n* Known additional malignancy that is progressing or has required active treatment within the past 3 years.\n* Known active CNS metastases and/or carcinomatous meningitis.\n* Active autoimmune disease that has required systemic treatment in past 2 years.\n* History of non-infectious pneumonitis that required steroids or has current pneumonitis.\n* Active infection requiring systemic therapy.\n* Recent (within the last 12 months) or current GI ulcer, colitis or non-immune colitis.\n* Known history of human immunodeficiency virus (HIV) infection, Hepatitis B, or active Hepatitis C virus infection.\n* Clinically significant (i.e. active) cardiovascular disease\n* Allogeneic tissue/solid organ transplant\n* Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Male and female adult patients 18 years of age or older on day of signing informed consent.",
"criterions": [
{
"exact_snippets": "Male and female adult patients",
"criterion": "gender",
"requirement": {
"requirement_type": "presence",
"expected_value": [
"male",
"female"
]
}
},
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Male and female adult patients",
"criterion": "gender",
"requirement": {
"requirement_type": "presence",
"expected_value": [
"male",
"female"
]
}
},
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Adequate organ function.",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Able to swallow and absorb oral tablets.",
"criterions": [
{
"exact_snippets": "Able to swallow",
"criterion": "swallowing ability",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
},
{
"exact_snippets": "absorb oral tablets",
"criterion": "absorption of oral tablets",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Able to swallow",
"criterion": "swallowing ability",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
},
{
"exact_snippets": "absorb oral tablets",
"criterion": "absorption of oral tablets",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor",
"criterions": [
{
"exact_snippets": "Prior therapy with an anti-PD-1",
"criterion": "prior therapy with anti-PD-1 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Prior therapy with an ... anti-PD-L1",
"criterion": "prior therapy with anti-PD-L1 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Prior therapy with an ... anti-PD-L2 agent",
"criterion": "prior therapy with anti-PD-L2 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Prior therapy with an ... agent directed to another stimulatory or co-inhibitory T-cell receptor",
"criterion": "prior therapy with agent directed to another stimulatory or co-inhibitory T-cell receptor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Prior therapy with an anti-PD-1",
"criterion": "prior therapy with anti-PD-1 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Prior therapy with an ... anti-PD-L1",
"criterion": "prior therapy with anti-PD-L1 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Prior therapy with an ... anti-PD-L2 agent",
"criterion": "prior therapy with anti-PD-L2 agent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Prior therapy with an ... agent directed to another stimulatory or co-inhibitory T-cell receptor",
"criterion": "prior therapy with agent directed to another stimulatory or co-inhibitory T-cell receptor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Current use of NSAIDs, COX-2 inhibitors and aspirin products within 3 days (preferably 7 days) before treatment initiation or at anytime during the study unless used for management of AE.",
"criterions": [
{
"exact_snippets": "Current use of NSAIDs",
"criterion": "NSAID use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
},
{
"exact_snippets": "Current use of ... COX-2 inhibitors",
"criterion": "COX-2 inhibitor use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
},
{
"exact_snippets": "Current use of ... aspirin products",
"criterion": "aspirin product use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Current use of NSAIDs",
"criterion": "NSAID use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
},
{
"not_criteria": {
"exact_snippets": "unless used for management of AE",
"criterion": "use for management of AE",
"requirement": {
"requirement_type": "purpose",
"expected_value": true
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Current use of ... COX-2 inhibitors",
"criterion": "COX-2 inhibitor use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
},
{
"not_criteria": {
"exact_snippets": "unless used for management of AE",
"criterion": "use for management of AE",
"requirement": {
"requirement_type": "purpose",
"expected_value": true
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Current use of ... aspirin products",
"criterion": "aspirin product use",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 3 days before treatment initiation or at anytime during the study"
}
},
{
"not_criteria": {
"exact_snippets": "unless used for management of AE",
"criterion": "use for management of AE",
"requirement": {
"requirement_type": "purpose",
"expected_value": true
}
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterions": [
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "antibody type",
"expected_value": [
"chimeric",
"humanized"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"exact_snippets": "History of severe hypersensitivity reactions to chimeric or humanized antibodies",
"criterion": "hypersensitivity reactions",
"requirement": {
"requirement_type": "antibody type",
"expected_value": [
"chimeric",
"humanized"
]
}
}
]
}
},
{
"identified_line": {
"line": "* Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.",
"criterions": [
{
"exact_snippets": "Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.",
"criterion": "prior systemic anticancer therapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4,
"unit": "weeks"
}
]
}
}
},
{
"exact_snippets": "Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.",
"criterion": "prior systemic anticancer therapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "half-lives"
}
]
}
}
}
]
},
"logical_structure": {
"xor_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.",
"criterion": "prior systemic anticancer therapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4,
"unit": "weeks"
}
]
}
}
},
{
"exact_snippets": "Has received prior systemic anticancer therapy including investigational agents within 4 weeks prior to treatment, or 5 half-lives, whichever is shorter.",
"criterion": "prior systemic anticancer therapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "half-lives"
}
]
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study drug.",
"criterions": [
{
"exact_snippets": "Diagnosis of immunodeficiency",
"criterion": "immunodeficiency",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
},
{
"exact_snippets": "receiving chronic systemic steroid therapy ... exceeding 10 mg daily of prednisone equivalent",
"criterion": "chronic systemic steroid therapy",
"requirement": {
"requirement_type": "dosage",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "mg daily of prednisone equivalent"
}
}
},
{
"exact_snippets": "receiving ... any other form of immunosuppressive therapy within 7 days prior the first dose of study drug",
"criterion": "immunosuppressive therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days prior the first dose of study drug"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Diagnosis of immunodeficiency",
"criterion": "immunodeficiency",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "receiving chronic systemic steroid therapy ... exceeding 10 mg daily of prednisone equivalent",
"criterion": "chronic systemic steroid therapy",
"requirement": {
"requirement_type": "dosage",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "mg daily of prednisone equivalent"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "receiving ... any other form of immunosuppressive therapy within 7 days prior the first dose of study drug",
"criterion": "immunosuppressive therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days prior the first dose of study drug"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Known additional malignancy that is progressing or has required active treatment within the past 3 years.",
"criterions": [
{
"exact_snippets": "Known additional malignancy",
"criterion": "additional malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "is progressing",
"criterion": "additional malignancy progression",
"requirement": {
"requirement_type": "status",
"expected_value": "progressing"
}
},
{
"exact_snippets": "has required active treatment within the past 3 years",
"criterion": "additional malignancy treatment",
"requirement": {
"requirement_type": "treatment requirement",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Known additional malignancy",
"criterion": "additional malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "is progressing",
"criterion": "additional malignancy progression",
"requirement": {
"requirement_type": "status",
"expected_value": "progressing"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Known additional malignancy",
"criterion": "additional malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "has required active treatment within the past 3 years",
"criterion": "additional malignancy treatment",
"requirement": {
"requirement_type": "treatment requirement",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "years"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Known active CNS metastases and/or carcinomatous meningitis.",
"criterions": [
{
"exact_snippets": "Known active CNS metastases",
"criterion": "CNS metastases",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "carcinomatous meningitis",
"criterion": "carcinomatous meningitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Known active CNS metastases",
"criterion": "CNS metastases",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "carcinomatous meningitis",
"criterion": "carcinomatous meningitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Active autoimmune disease that has required systemic treatment in past 2 years.",
"criterions": [
{
"exact_snippets": "Active autoimmune disease that has required systemic treatment in past 2 years.",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Active autoimmune disease that has required systemic treatment in past 2 years.",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "treatment",
"expected_value": "systemic treatment in past 2 years"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Active autoimmune disease that has required systemic treatment in past 2 years.",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Active autoimmune disease that has required systemic treatment in past 2 years.",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "treatment",
"expected_value": "systemic treatment in past 2 years"
}
}
]
}
},
{
"identified_line": {
"line": "* History of non-infectious pneumonitis that required steroids or has current pneumonitis.",
"criterions": [
{
"exact_snippets": "History of non-infectious pneumonitis that required steroids",
"criterion": "non-infectious pneumonitis",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of non-infectious pneumonitis that required steroids",
"criterion": "non-infectious pneumonitis",
"requirement": {
"requirement_type": "treatment",
"expected_value": "steroids"
}
},
{
"exact_snippets": "current pneumonitis",
"criterion": "pneumonitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of non-infectious pneumonitis that required steroids",
"criterion": "non-infectious pneumonitis",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of non-infectious pneumonitis that required steroids",
"criterion": "non-infectious pneumonitis",
"requirement": {
"requirement_type": "treatment",
"expected_value": "steroids"
}
}
]
},
{
"exact_snippets": "current pneumonitis",
"criterion": "pneumonitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Active infection requiring systemic therapy.",
"criterions": [
{
"exact_snippets": "Active infection requiring systemic therapy.",
"criterion": "active infection",
"requirement": {
"requirement_type": "treatment",
"expected_value": "systemic therapy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Active infection requiring systemic therapy.",
"criterion": "active infection",
"requirement": {
"requirement_type": "treatment",
"expected_value": "systemic therapy"
}
}
]
}
},
{
"identified_line": {
"line": "* Recent (within the last 12 months) or current GI ulcer, colitis or non-immune colitis.",
"criterions": [
{
"exact_snippets": "Recent (within the last 12 months) or current GI ulcer",
"criterion": "GI ulcer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current GI ulcer",
"criterion": "GI ulcer",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... colitis",
"criterion": "colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... colitis",
"criterion": "colitis",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... non-immune colitis",
"criterion": "non-immune colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... non-immune colitis",
"criterion": "non-immune colitis",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Recent (within the last 12 months) or current GI ulcer",
"criterion": "GI ulcer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current GI ulcer",
"criterion": "GI ulcer",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Recent (within the last 12 months) or current ... colitis",
"criterion": "colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... colitis",
"criterion": "colitis",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
}
]
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Recent (within the last 12 months) or current ... non-immune colitis",
"criterion": "non-immune colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Recent (within the last 12 months) or current ... non-immune colitis",
"criterion": "non-immune colitis",
"requirement": {
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 12,
"unit": "months"
}
]
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Known history of human immunodeficiency virus (HIV) infection, Hepatitis B, or active Hepatitis C virus infection.",
"criterions": [
{
"exact_snippets": "Known history of human immunodeficiency virus (HIV) infection",
"criterion": "HIV infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Hepatitis B",
"criterion": "Hepatitis B infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "active Hepatitis C virus infection",
"criterion": "Hepatitis C infection",
"requirement": {
"requirement_type": "status",
"expected_value": "active"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Known history of human immunodeficiency virus (HIV) infection",
"criterion": "HIV infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Hepatitis B",
"criterion": "Hepatitis B infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "active Hepatitis C virus infection",
"criterion": "Hepatitis C infection",
"requirement": {
"requirement_type": "status",
"expected_value": "active"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Clinically significant (i.e. active) cardiovascular disease",
"criterions": [
{
"exact_snippets": "Clinically significant (i.e. active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Clinically significant (i.e. active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "clinical significance",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Clinically significant (i.e. active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Clinically significant (i.e. active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "clinical significance",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Allogeneic tissue/solid organ transplant",
"criterions": [
{
"exact_snippets": "Allogeneic tissue/solid organ transplant",
"criterion": "allogeneic tissue/solid organ transplant",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Allogeneic tissue/solid organ transplant",
"criterion": "allogeneic tissue/solid organ transplant",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
}
],
"miscellaneous_lines": [
{
"identified_line": {
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
}
}
],
"failed_inclusion": [
{
"identified_line": {
"line": "* Patients must have a histologically confirmed advanced, metastatic, or progressive Microsatellite Stable (MSS) Colorectal Cancer (CRC) per institutional standards.",
"criterions": [
{
"exact_snippets": "histologically confirmed",
"criterion": "histological confirmation",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "advanced, metastatic, or progressive",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"advanced",
"metastatic",
"progressive"
]
}
},
{
"exact_snippets": "Microsatellite Stable (MSS)",
"criterion": "microsatellite stability",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable"
}
},
{
"exact_snippets": "Colorectal Cancer (CRC)",
"criterion": "cancer type",
"requirement": {
"requirement_type": "type",
"expected_value": "Colorectal Cancer"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed",
"criterion": "histological confirmation",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "Colorectal Cancer (CRC)",
"criterion": "cancer type",
"requirement": {
"requirement_type": "type",
"expected_value": "Colorectal Cancer"
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "advanced, metastatic, or progressive",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "advanced"
}
},
{
"exact_snippets": "advanced, metastatic, or progressive",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "metastatic"
}
},
{
"exact_snippets": "advanced, metastatic, or progressive",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "progressive"
}
}
]
},
{
"exact_snippets": "Microsatellite Stable (MSS)",
"criterion": "microsatellite stability",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable"
}
}
]
}
},
{
"identified_line": {
"line": "* Patient has received at least two prior lines of therapy for advanced or metastatic CRC, at least one of which included fluorouracil.",
"criterions": [
{
"exact_snippets": "Patient has received at least two prior lines of therapy for advanced or metastatic CRC",
"criterion": "prior lines of therapy for advanced or metastatic CRC",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "lines"
}
}
},
{
"exact_snippets": "at least one of which included fluorouracil",
"criterion": "prior therapy including fluorouracil",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "lines"
}
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Highly effective birth control.",
"criterions": [
{
"exact_snippets": "Highly effective birth control",
"criterion": "birth control",
"requirement": {
"requirement_type": "effectiveness",
"expected_value": "highly effective"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Measurable disease.",
"criterions": [
{
"exact_snippets": "Measurable disease",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Accessible tumor that can be safely accessed for multiple core biopsies and patient is willing to provide tissue from newly obtain biopsies before and during treatment.",
"criterions": [
{
"exact_snippets": "Accessible tumor that can be safely accessed for multiple core biopsies",
"criterion": "tumor accessibility",
"requirement": {
"requirement_type": "accessibility",
"expected_value": true
}
},
{
"exact_snippets": "patient is willing to provide tissue from newly obtain biopsies before and during treatment",
"criterion": "patient willingness to provide tissue",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterions": [
{
"exact_snippets": "Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "concomitant administration",
"expected_value": [
"strong CYP3A4 inhibitors",
"strong CYP3A4 inducers",
"P glycoprotein inhibitors",
"P glycoprotein inducers"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "concomitant administration",
"expected_value": "strong CYP3A4 inhibitors"
}
},
{
"exact_snippets": "Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "concomitant administration",
"expected_value": "strong CYP3A4 inducers"
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "concomitant administration",
"expected_value": "P glycoprotein inhibitors"
}
},
{
"exact_snippets": "Medical conditions requiring concomitant administration of strong CYP3A4 or P glycoprotein inhibitors or inducers.",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "concomitant administration",
"expected_value": "P glycoprotein inducers"
}
}
]
}
]
}
]
}
}
],
"failed_miscellaneous": []
}